Reaction
Eosinophilic Pneumonia Acute reporting signals
As of the last recalculation, Eosinophilic Pneumonia Acute appears in 851 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is DAPTOMYCIN (PRR 459.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Daptomycin | 144 | 459.3 | 466.6 |
| Minocycline | 53 | 118.5 | 119.1 |
| Rifampicin | 21 | 52.0 | 52.1 |
| Amiodarone Hydrochloride | 20 | 44.7 | 44.8 |
| Piperacillin And Tazobactam | 19 | 37.1 | 37.2 |
| Progesterone | 28 | 30.9 | 31.0 |
| Piperacillin Sodium And Tazobactam Sodium | 24 | 30.8 | 30.8 |
| Piperacillin Sodium,Tazobactam Sodium | 31 | 29.6 | 29.7 |
| Ceftriaxone | 31 | 23.9 | 24.0 |
| Meropenem | 29 | 22.8 | 22.9 |
| Sevoflurane | 7 | 20.8 | 20.8 |
| Cefepime | 12 | 20.8 | 20.8 |
| Ceftriaxone Sodium | 31 | 20.5 | 20.5 |
| Cefepime Hydrochloride | 13 | 20.0 | 20.0 |
| Vancomycin Hydrochloride | 50 | 19.6 | 19.7 |
| Vancomycin | 41 | 18.2 | 18.2 |
| Levofloxacin | 38 | 16.1 | 16.1 |
| Levofloxacin In 5% Dextrose | 38 | 16.1 | 16.1 |
| Brentuximab Vedotin | 6 | 14.4 | 14.4 |
| Linezolid | 17 | 14.2 | 14.2 |
| Naltrexone | 15 | 12.1 | 12.1 |
| Isotretinoin | 13 | 6.5 | 6.5 |